MedTrace Logo

A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers

NCT07277712 · Status: NOT_YET_RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2025-12-11

No results posted yet for this study

Summary

This study aims to evaluate the pharmacokinetic (PK) following administration of IN-M00002 tablet and co-administration of tegoprazan and naproxen, and to evaluate food-effect of IN-M00002 tablet in healthy adult volunteers

Conditions

  • Healthy Volunteer

Interventions

DRUG

Tegoprazan

Tegoprazan 25 mg QD

DRUG

Naproxen

Naproxen 500 mg BID

DRUG

IN-M00002

IN-M00002 tablet QD

DRUG

IN-M00002

IN-M00002 tablet BID

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Seol Ju Moon, MD, Ph.D · Clinical Pharmacology Center, Jeonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-27
Primary Completion
2026-05-30
Completion
2026-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07277712 on ClinicalTrials.gov